Filing Details

Accession Number:
0001209191-22-047653
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-25 19:37:05
Reporting Period:
2022-08-25
Accepted Time:
2022-08-25 19:37:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1636282 Aeglea Biotherapeutics Inc. AGLE Pharmaceutical Preparations (2834) 464312787
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1707657 Marcio Souza C/O Aeglea Biotherapeutics, Inc.
805 Las Cimas Parkway, #100
Austin TX 78746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-25 90,000 $0.56 90,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct